Predicted risk of radiation-induced cancers after involved field and involved node radiotherapy with or without intensity modulation for early-stage Hodgkin lymphoma in female patients

International Journal of Radiation Oncology Biology Physics

Volumn 81, Issue 2, 2011, Pages 490-497

  Weber, Damien C ^a   Johanson, Safora ^b   Peguret, Nicolas ^a   Cozzi, Luca ^c   Olsen, Dag R ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

Author keywords

Hodgkin lymphoma; IMRT; Radiation induced cancer; RapidArc

Indexed keywords

CANCER INDUCTION; EXCESS RELATIVE RISKS; HODGKIN LYMPHOMA; IMRT; INTENSITY MODULATIONS; INVOLVED FIELD; NON-LINEAR MODEL; ORGANS AT RISKS; PARAMETERIZED MODEL; RADIATION DELIVERY; RADIATION FIELD; RADIATION-INDUCED CANCER; RAPIDARC; RISK MODEL;

BIOLOGICAL ORGANS; DISEASES; NONLINEAR SYSTEMS; ONCOLOGY; PATIENT MONITORING; RADIATION; RADIOTHERAPY; RISK ASSESSMENT; RISK PERCEPTION;

PHYSICAL THERAPY;

ADULT; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; EARLY CANCER; FEMALE; HISTOGRAM; HODGKIN DISEASE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; LUNG CANCER; LYMPH NODE IRRADIATION; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RADIATION DOSE; RADIATION FIELD; RADIATION HAZARD; RISK ASSESSMENT; STATISTICAL MODEL; THYROID CANCER; TREATMENT PLANNING; VOLUMETRIC MODULATED ARC RADIATION THERAPY;

ADULT; BREAST NEOPLASMS; FEMALE; HODGKIN DISEASE; HUMANS; LINEAR MODELS; LUNG NEOPLASMS; LYMPHATIC IRRADIATION; NEOPLASM STAGING; NEOPLASMS, RADIATION-INDUCED; ORGANS AT RISK; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; RISK; THYROID NEOPLASMS;

EID: 80052784878     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.05.035     Document Type: Article

References (31)

1. G.M. Dores, C. Metayer, and R.E. Curtis Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years J Clin Oncol 20 2002 3484 3494
2. O. Favier, N. Heutte, and A. Stamatoullas-Bastard Survival after Hodgkin lymphoma: Causes of death and excess mortality in patients treated in 8 consecutive trials Cancer 115 2009 1680 1691
3. E.S. Koh, T.H. Tran, and M. Heydarian A comparison of mantle versus involved field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk Radiat Oncol 2 2007 13
4. S. Johansen, L. Cozzi, and D.R. Olsen A planning comparison of dose patterns in organs at risk and predicted risk for radiation induced malignancy in the contralateral breast following radiation therapy of primary breast using conventional, IMRT and volumetric modulated arc treatment techniques Acta Oncol 48 2009 495 503
5. T. Girinsky, R. van der Maazen, and L. Specht Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines Radiother Oncol 79 2006 270 277 (Pubitemid 44109907)
6. J. Yahalom, and P. Mauch The involved field is back: Issues in delineating the radiation field in Hodgkin's disease Ann Oncol 13 Suppl 1 2002 79 83 (Pubitemid 34567406)
7. D.C. Weber, N. Peguret, and G. Dipasquale Involved-node and involved field volumetric modulated arc vs. fixed beam intensity-modulated radiotherapy for female patients with early-stage supra-diaphragmatic Hodgkin lymphoma: A comparative planning study Int J Rad Oncol Biol Phys 75 2009 1578 1586
8. S. Johansen, T. Danielsen, and D.R. Olsen Estimated risk for secondary cancer in the contra-lateral breast following radiation therapy of breast cancer Acta Oncol 47 2008 391 396 (Pubitemid 351414937)
9. D.L. Preston, A. Mattsson, and E. Holmberg Radiation effects on breast cancer risk: A pooled analysis of eight cohorts Radiat Res 158 2002 220 235 (Pubitemid 34851818)
10. E.J. Hall, and C.S. Wuu Radiation-induced second cancers: the impact of 3D-CRT and IMRT Int J Radiat Oncol Biol Phys 56 2003 83 88 (Pubitemid 36403679)
11. A. Dasu, I. Toma-Dasu, and J. Olofsson The use of risk estimation models for the induction of secondary cancers following radiotherapy Acta Oncol 44 2005 339 347 (Pubitemid 41021038)
12. G. Steel Basic clinical radiobiology Oxford 2002 Arnold
13. R.K. Sachs, and D. Brenner Solid tumor risks after high doses of ionizing radiation Proc Natl Acad Sci U S A 102 2005 13040 13045 (Pubitemid 41324975)
14. D.C. Hodgson, E.S. Koh, and T.H. Tran Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin lymphoma Cancer 110 2007 2576 2586 (Pubitemid 350174945)
15. J. Franklin, A. Pluetschow, and M. Paus Second malignancy risk associated with treatment of Hodgkin's lymphoma: Meta-analysis of the randomised trials Ann Oncol 17 2006 1749 1760 (Pubitemid 44884048)
16. M.L. De Bruin, J. Sparidans, and M.B. van't Veer Breast cancer risk in female survivors of Hodgkin's lymphoma: Lower risk after smaller radiation volumes J Clin Oncol 27 2009 4239 4246
17. B.A. Campbell, N. Voss, T. Pickles, J. Morris, R.D. Gascoyne, and K.J. Savage Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: a question of field size J Clin Oncol 26 32 2008 Nov 10 5170 5174
18. H.T. Eich, R.P. Muller, and R. Engenhart-Cabillic Involved-node radiotherapy in early-stage Hodgkin's lymphoma. Definition and guidelines of the German Hodgkin Study Group (GHSG) Strahlenther Onkol 184 2008 406 410
19. L.B. Travis, D. Hill, and G.M. Dores Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma J Natl Cancer Inst 97 2005 1428 1437 (Pubitemid 41520078)
20. A.K. Ng, M.P. Bernardo, and E. Weller Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger J Clin Oncol 20 2002 2101 2108 (Pubitemid 34408801)
21. U. Schneider, A. Lomax, and P. Pemler The impact of IMRT and proton radiotherapy on secondary cancer incidence Strahlenther Onkol 182 2006 647 652 (Pubitemid 44657651)
22. U. Schneider, A. Lomax, and N. Lombriser Comparative risk assessment of secondary cancer incidence after treatment of Hodgkin's disease with photon and proton radiation Radiat Res 154 2000 382 388
23. L.B. Travis, D.A. Hill, and G.M. Dores Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease JAMA 290 2003 465 475 (Pubitemid 37430500)
24. F.E. van Leeuwen, W.J. Klokman, and M. Stovall Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease J Natl Cancer Inst 95 2003 971 980 (Pubitemid 36896714)
25. K.A. Lindsay, E.G. Wheldon, and C. Deehan Radiation carcinogenesis modelling for risk of treatment-related second tumours following radiotherapy Br J Radiol 74 2001 529 536 (Pubitemid 32674214)
26. A.C. Upton Radiobiological effects of low doses. Implications for radiological protection Radiat Res 71 1977 51 74 (Pubitemid 8155717)
27. R. Epstein, I. Hanham, and R. Dale Radiotherapy-induced second cancers: are we doing enough to protect young patients? Eur J Cancer 33 1997 526 530 (Pubitemid 27223732)
28. W. Dorr, and T. Herrmann Second primary tumors after radiotherapy for malignancies. Treatment-related parameters Strahlenther Onkol 178 2002 357 362 (Pubitemid 34665782)
29. P. Karlsson, E. Holmberg, and K.A. Johansson Soft tissue sarcoma after treatment for breast cancer Radiother Oncol 38 1996 25 31 (Pubitemid 26040265)
30. H. Suit, S. Goldberg, and A. Niemierko Secondary carcinogenesis in patients treated with radiation: a review of data on radiation-induced cancers in human, non-human primate, canine and rodent subjects Radiat Res 167 2007 12 42 (Pubitemid 46106795)
31. R.K. Sachs, I. Shuryak, and D. Brenner Second cancers after fractionated radiotherapy: Stochastic population dynamics effects J Theor Biol 249 2007 518 531 (Pubitemid 350046627)